The Oncology Institute Inc
(TOI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,424 | 36,055 | 33,488 | 27,535 | 28,892 |
| Marketable Securities | 9,939 | 29,777 | 49,367 | 59,877 | 10,291 |
| Receivables | 54,367 | 59,128 | 42,911 | 48,906 | 46,893 |
| Inventories | 11,322 | 11,554 | 13,678 | 12,174 | 12,168 |
| TOTAL | $116,209 | $141,192 | $143,493 | $152,682 | $104,071 |
| Non-Current Assets | |||||
| PPE Net | 12,232 | 10,995 | 10,883 | 10,787 | 10,772 |
| Investments And Advances | 0 | 0 | 0 | 0 | 58,944 |
| Intangibles | 23,587 | 24,361 | 25,134 | 25,791 | 26,574 |
| Other Non-Current Assets | 27,574 | 27,984 | 29,730 | 29,093 | 29,598 |
| TOTAL | $63,393 | $63,340 | $65,747 | $65,671 | $125,888 |
| Total Assets | $179,602 | $204,532 | $209,240 | $218,353 | $229,959 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,750 | 21,015 | 14,429 | 13,333 | 13,123 |
| Accrued Expenses | 12,831 | 18,363 | 13,996 | 12,723 | 14,126 |
| TOTAL | $35,102 | $45,768 | $34,788 | $32,390 | $33,506 |
| Non-Current Liabilities | |||||
| Long Term Debt | 89,950 | 88,385 | 86,826 | 85,254 | 83,688 |
| Other Non-Current Liabilities | 25,312 | 29,051 | 30,569 | 28,702 | 27,965 |
| TOTAL | $115,294 | $117,468 | $117,427 | $114,114 | $111,731 |
| Total Liabilities | $150,396 | $163,236 | $152,215 | $146,504 | $145,237 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,490 | 74,438 | 74,313 | 73,749 | 72,955 |
| Common Shares | 8 | 8 | 8 | 8 | 7 |
| Retained earnings | -181,518 | -166,039 | -146,150 | -127,396 | -109,977 |
| Other shareholders' equity | -19 | -19 | -19 | -19 | 106 |
| TOTAL | $29,206 | $41,296 | $57,025 | $71,849 | $84,722 |
| Total Liabilities And Equity | $179,602 | $204,532 | $209,240 | $218,353 | $229,959 |